Companies: 10,795·Total market cap: $144.5T
Cano Health, Inc.

Cano Health, Inc.

CANONYSEHealthcare
$2.30
$-0.05(-2.13%)
Market Cap$12434950
P/E Ratio
52W High$190.0
52W Low$1.739

Cano Health, Inc. (CANO) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

cano · stock forecast · 10 analysts (3M) · FMP

Analyst Rating & Consensus

Based on 10 Wall Street analysts in the past 3 months

SellBuy

Hold

10 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
0
Hold
8
Sell
2
Strong Sell
0
Total: 10 · Buy rate: 0.0%

12-Month Price Target

High

$832

Consensus

$402

+17392.6% upside

Low

$125

Median: $250 · Last Close: $2.30

The Cano Health, Inc. (CANO) analyst consensus is Hold, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month CANO price target is $402.33, representing +17392.6% upside from the current price of $2.30.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Analyst price target coverage is insufficient to generate a forecast chart for this stock.

Short-Term Price Prediction

Short-term price predictions will be available once the prediction engine is ready.

Long-Term Stock Price Prediction

Long-term price predictions will be available once the prediction engine is ready.

Stock Forecast Based on Technical Analysis

Technical analysis will be available once the prediction engine is ready.

Latest Analyst Ratings & Upgrades

Filter:

Wall Street analysts have recently issued updated ratings on Cano Health, Inc. (CANO) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 10 analysts currently cover CANO.

Analyst Recommendation Trends

CANO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

Revenue Next Year

EPS This Year

EPS Next Year

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CANO EPS of $ for the current fiscal year, based on estimates from 0 analysts. The CANO revenue forecast is for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The CANO stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CANO price target is $402.33 (+17392.6% upside), with an analyst consensus of Hold.

Cano Health, Inc. trades on NYSE under the ticker CANO. The CANO stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 0% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

CANO forecast · 8 questions

According to 10 Wall Street analysts, the average 12-month CANO price target is $402.33, with a high forecast of $832.00 and a low of $125.00. The median price target is shown in the chart above when available. This implies +17392.6% potential upside from the current price of $2.30.

CANO price targetWhat is CANO price targetCANO analyst price targetCANO 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.